Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients.

Balloy G, Pelletier J, Suchet L, Lebrun C, Cohen M, Vermersch P, Zephir H, Duhin E, Gout O, Deschamps R, Le Page E, Edan G, Labauge P, Carra-Dallieres C, Rumbach L, Berger E, Lejeune P, Devos P, N'Kendjuo JB, Coustans M, Auffray-Calvier E, Daumas-Duport B, Michel L, Lefrere F, Laplaud DA, Brosset C, Derkinderen P, de Seze J, Wiertlewski S; Société Francophone de la Sclérose en Plaques.

J Neurol. 2018 Oct;265(10):2251-2259. doi: 10.1007/s00415-018-8984-7. Epub 2018 Jul 27.

PMID:
30054790
2.

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study.

Cobo-Calvo A, Ruiz A, Maillart E, Audoin B, Zephir H, Bourre B, Ciron J, Collongues N, Brassat D, Cotton F, Papeix C, Durand-Dubief F, Laplaud D, Deschamps R, Cohen M, Biotti D, Ayrignac X, Tilikete C, Thouvenot E, Brochet B, Dulau C, Moreau T, Tourbah A, Lebranchu P, Michel L, Lebrun-Frenay C, Montcuquet A, Mathey G, Debouverie M, Pelletier J, Labauge P, Derache N, Coustans M, Rollot F, De Seze J, Vukusic S, Marignier R; OFSEP and NOMADMUS Study Group.

Neurology. 2018 May 22;90(21):e1858-e1869. doi: 10.1212/WNL.0000000000005560. Epub 2018 Apr 25.

PMID:
29695592
3.

Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?

Rouzaud C, Hautecoeur P, Donze C, Heinzlef O, Dinh A; Club Francophone de la Sclérose en Plaque, Creange A, Abdullatif A, Audouin B, Tourbah A, Berger E, Bourre B, Brochet B, Mekies C, Cabre P, Papeix C, Casez O, Brassat D, Defer G, Derache N, De Seze J, Dive D, LePage E, Fromont A, Gouider R, Edan G, Pelletier J, Grimaud J, Guennoc AM, Camdessanché JP, Kwiatkowski A, Laplaud D, Lebrun C, Debouverie M, Coustans M, Gout O, La Rochelle OA, Heinzlef O, Ouallet JC, Cavelou P, Hautecoeur P, Labauge P, Vermersch P, Wiertlewski S, Vukusic S, Marignier R, Schluep M, Seeldrayers P, Slassi I, Stankoff B, Thaite F, Moreau T, Thouvenot E, Zephir H, Ciron J, Collongues N, Kerschen P, Cohen M, Gueguen A, Mathey G, Carra C, Bernady P, Faucheux JM, Planque E, Donze C, Ruet A, Mouzawakh C, Pittion S.

Mult Scler Relat Disord. 2017 Nov;18:161-163. doi: 10.1016/j.msard.2017.08.009. Epub 2017 Aug 24. No abstract available.

PMID:
29141801
4.

Erdheim Chester disease: A rare obstructive case of acute renal failure.

Jean-Michel V, Coustans M, Wehbe B, Metes I, Siohan P.

Presse Med. 2016 Nov;45(11):1066-1069. doi: 10.1016/j.lpm.2016.07.010. Epub 2016 Sep 3. No abstract available.

PMID:
27597297
5.

Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.

Le Page E, Veillard D, Laplaud DA, Hamonic S, Wardi R, Lebrun C, Zagnoli F, Wiertlewski S, Deburghgraeve V, Coustans M, Edan G; COPOUSEP investigators; West Network for Excellence in Neuroscience.

Lancet. 2015 Sep 5;386(9997):974-81. doi: 10.1016/S0140-6736(15)61137-0. Epub 2015 Jun 28. Erratum in: Lancet. 2016 Jan 23;387(10016):340.

6.

[Intravascular large B-cell lymphoma revealed by a cerebral infarct and a mesenteric ischemia].

Bailly P, Diraison P, Coustans M, Lamotte N, Breuilly C.

Presse Med. 2015 Feb;44(2):244-7. doi: 10.1016/j.lpm.2014.09.015. Epub 2014 Dec 24. French. No abstract available.

PMID:
25542708
7.

'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.

Leray E, Coustans M, Le Page E, Yaouanq J, Oger J, Edan G.

Mult Scler. 2013 Apr;19(4):458-65. doi: 10.1177/1352458512456613. Epub 2012 Aug 2.

PMID:
22859724
8.

Natalizumab and drug holiday in clinical practice: an observational study in very active relapsing remitting multiple sclerosis patients.

Kerbrat A, Le Page E, Leray E, Anani T, Coustans M, Desormeaux C, Guiziou C, Kassiotis P, Lallement F, Laplaud D, Diraison P, Rouhart F, Sartori E, Wardi R, Wiertlewski S, Edan G.

J Neurol Sci. 2011 Sep 15;308(1-2):98-102. doi: 10.1016/j.jns.2011.05.043. Epub 2011 Jun 12.

PMID:
21665227
9.

Acute urinary retention due to a novel collagen COL4A1 mutation.

Rouaud T, Labauge P, Tournier Lasserve E, Mine M, Coustans M, Deburghgraeve V, Edan G.

Neurology. 2010 Aug 24;75(8):747-9. doi: 10.1212/WNL.0b013e3181eee440. No abstract available.

PMID:
20733150
10.

Evidence for a two-stage disability progression in multiple sclerosis.

Leray E, Yaouanq J, Le Page E, Coustans M, Laplaud D, Oger J, Edan G.

Brain. 2010 Jul;133(Pt 7):1900-13. doi: 10.1093/brain/awq076. Epub 2010 Apr 27.

11.

Long-term survival of patients with multiple sclerosis in West France.

Leray E, Morrissey S, Yaouanq J, Coustans M, Le Page E, Chaperon J, Edan G.

Mult Scler. 2007 Aug;13(7):865-74.

PMID:
17881399
12.

Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients.

Le Page E, Leray E, Taurin G, Coustans M, Chaperon J, Morrissey SP, Edan G.

J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):52-6. Epub 2007 Sep 10.

PMID:
17846110
13.

Spontaneous resolution of arachnoid cysts: review and features of an unusual case.

Seizeur R, Forlodou P, Coustans M, Dam-Hieu P.

Acta Neurochir (Wien). 2007 Jan;149(1):75-8; discussion 78. Epub 2006 Dec 21. Review.

PMID:
17180304
14.

[Mitoxantrone as induction therapy in aggressive relapsing remitting multiple sclerosis: a descriptive analysis of 100 consecutive patients].

Le Page E, Leray E, Taurin G, Coustans M, Chaperon J, Edan G.

Rev Neurol (Paris). 2006 Feb;162(2):185-94. French.

PMID:
16518258
15.

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, Achiti I, Confavreux C, Coustans M, le Page E, Edan G, McDonnell GV, Hawkins S, Trojano M, Liguori M, Cocco E, Marrosu MG, Tesser F, Leone MA, Weber A, Zipp F, Miterski B, Epplen JT, Oturai A, Sørensen PS, Celius EG, Lara NT, Montalban X, Villoslada P, Silva AM, Marta M, Leite I, Dubois B, Rubio J, Butzkueven H, Kilpatrick T, Mycko MP, Selmaj KW, Rio ME, Sá M, Salemi G, Savettieri G, Hillert J, Compston DA.

Neurology. 2005 Apr 12;64(7):1144-51.

PMID:
15824338
16.

[Is immunosuppression a future therapeutic strategy for multiple sclerosis?].

Edan G, Coustans M.

Pathol Biol (Paris). 2000 Mar;48(2):114-20. Review. French.

PMID:
10815287
17.

[Evolution and surveillance of multiple sclerosis].

Edan G, Coustans M.

Rev Prat. 1999 Nov 1;49(17):1866-71. French.

PMID:
10598502

Supplemental Content

Loading ...
Support Center